Respiratory Syncytial Virus (RSV)
Following last year’s advice from the Joint Committee on Vaccination and Immunisation (JCVI), Public Health Scotland has been working with the Scottish Government and NHS boards to develop plans for the roll out of Scotland’s Respiratory Syncytial Virus (RSV) vaccination programme to protect newborns, infants and older adults.
RSV is a common respiratory virus that generally causes mild illness with cold-like symptoms. Most cases recover after 2-3 weeks of illness, but RSV can cause severe illness in some people, including newborns, infants and older adults, leading to complications and hospitalisation.
Learning Resources
Please note: These educational resources continue to be updated as required to support this programme but do not replace the clinical judgement of practitioners. Practitioners should refer to the UK Health Security Agency Green Book Chapter when administering the vaccine.
Webinar for Practitioners
A webinar for practitioners was hosted on: 17th July 2024 12:30-13:30.
Respiratory Syncytial Virus Immunisation (RSV) programme to protect infants and older Adults
Please be advised Captions and transcript will be enabled for the Webinar recording at the earliest opportunity.
RSV Vaccination Programme to Protect Infants
-
Slides - Read Only Version 1 160724
Instructional video of the storage and preparation for the administration of Abrysvo®.
NOTE, this video demonstrates preparation of the vaccine using the needle provided within the vaccine pack. NHS Boards may be using additional safety needles for administration, practitioners should check locally.
RSV Vaccination Programme to Protect Older Adults
-
Slides - Read Only Version 1 16072024
Instructional video of the storage and preparation for the administration of Abrysvo®.
NOTE, this video demonstrates preparation of the vaccine using the needle provided within the vaccine pack. NHS Boards may be using additional safety needles for administration, practitioners should check locally.